Prelude Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $211K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $35.5K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $28.5K | Sell |
|
|||||
|
2023
Q1 | $165K | Sell |
|
|||||
|
2022
Q4 | $199K | Buy |
|
|||||
|
2022
Q3 | $74K | Buy |
|
|||||
|
2022
Q2 | $53K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $135K | Hold |
|
|||||
|
2021
Q3 | $122K | Hold |
|
|||||
|
2021
Q2 | $217K | Hold |
|
|||||
|
2021
Q1 | $221K | Buy |
|
|||||
|
2020
Q4 | $285K | Hold |
|
|||||
|
2020
Q3 | $269K | Sell |
|
|||||
|
2020
Q2 | $360K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $3K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $9K | Buy |
|
|||||
|
2019
Q1 | $2K | Sell |
|
|||||
|
2018
Q4 | $3K | Sell |
|
|||||
|
2018
Q3 | $8K | Buy |
|
|||||
|
2018
Q2 | $5K | Buy |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $20K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $303K | Buy |
|